CClinicalTrials.gg
CompletedNCT00577213Updated Oct 26, 2012

Diagnosis of Hemangiomas and Vascular Malformations

An observational study in Hemangiomas, Vascular Malformations and Venular Malformations, sponsored by University of Arkansas. Completed. Open to participants aged Up to 75 Years. Per ClinicalTrials.gov, last updated 2012-10-26.

Sponsored by University of Arkansas · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
56
Ages
Up to 75 Years
Sex
All
01

Study summary

To develop a non-invasive, simple and affordable, measurement technique to differentiate hemangiomas from subtypes of VMS. The purpose of this study is to determine the best office based diagnositc instrument for differentiating the subtype of vascular lesions. The instrument must be simple and affordable so it can be used by primary car physicians in the doctor office. The procedure will be based on non-invasive and unharmful measurements that will be compared to the diagnosis from specialized physicians in this field and the final pathology.

02

Conditions studied

  • Hemangiomas
  • Vascular Malformations
  • Venular Malformations
  • Venous Malformations
  • Lymphatic Malformations
  • Arteriovenous Malformations

Keywords

  • Diagnosis
  • Hemangiomas
  • Vascular Malformations
  • Venular Malformations
  • Venous Malformations
  • Lymphatic Malformations
  • Arteriovenous Malformations
03

Who can participate

Ages eligible
Up to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects with vascular lesions from the patient populations at Arkansas Children's Hospital (ACH) and the University of Arkansas for Medical Sciences (UAMS) will be recruited for the study. Approximately 45 subjects from Arkansas Children's Hospital and approximately 10 subjects from the University of Arkansas for Medical Sciences will be recruited for a total of 55.

Inclusion criteria

  • Suspected Hemangioma, Vascular Malformations (VMS) including venular Malformations (port-wine stain, PWS), Venous Malformations, Lymphatic Malformations, Arteriovenous Malformations or mixed malformations.

Exclusion criteria

Exclusion Criteria:

  • All pregnant individuals will be excluded, since physiologic changes of pregnancy could alter characteristics of the vascular lesion.
04

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
56 participants (actual)
05

Study locations

No study locations are listed for this record.

06

Registry details

Key details

Study ID
NCT00577213
Lead sponsor
University of Arkansas
Responsible party
Sponsor
First posted
Dec 20, 2007
Start date
Feb 2007
Primary completion
Oct 2012
Completion
Oct 2012
Last update
Oct 26, 2012

Study contacts

Gal Shafirstein, Ph.D.
principal investigator · UAMS, ACH, Central Arkansas Veterans Healthcare System
Jessica L Boswell
study director · UAMS, ACH, Central Arkansas Veterans Healthcare System

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion